Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union

NCT ID: NCT03794622

Last Updated: 2020-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-14

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of bone marrow concentration on union of femoral shaft fracture by comparing clinical and imaging outcomes between patients receiving Intramedullary nail fixation with intraoperative bone marrow concentration and those receiving Intramedullary nail fixation only.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Femoral shaft fracture is a common orthopaedic injury. Intramedullary nail is one of the standard treatments. Its primary goal is to develop an osseous bridge between adjacent motion segments to prevent motion, relieve pain, and facilitate bone union. Delayed union or nonunion is common in femoral shaft fracture. Risk factors include comminuted fracture, open fracture, smoking, diabetes and open reduction of fracture fixation. Mesenchymal stem cells are pluripotent cells that can differentiate into multiple mesenchymal tissues, including tenocytes, chondrocytes and osteoblasts, as well as being a source of multiple growth factors to establish an environment conducive to soft and hard tissue regeneration. As bone marrow concentration has high concentration of mesenchymal stem cells, some studies have shown that autologous bone marrow concentration can improve bone healing. Therefore, the goal of this study was to evaluate the effect of bone marrow concentration on union of femoral shaft fracture.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Marrow Femoral Shaft Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bone marrow concentration group

Consecutive patients receive intramedullary nail fixation with bone marrow concentration.

intramedullary nail fixation with bone marrow concentration

Intervention Type OTHER

intramedullary nail fixation with bone marrow concentration

Historical control group

Previous age- and gender-matched patients who receive intramedullary nail fixation only.

intramedullary nail fixation

Intervention Type OTHER

intramedullary nail fixation only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intramedullary nail fixation with bone marrow concentration

intramedullary nail fixation with bone marrow concentration

Intervention Type OTHER

intramedullary nail fixation

intramedullary nail fixation only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* With recent diagnosis of femoral shaft fracture
* Treated with intramedullary nail fixation
* With one or more risk factors of non-union: comminuted fracture, open fracture, smoking, obesity, diabetes, open reduction,
* Age between 20 and 80 years

Exclusion Criteria

* Old femoral shaft fracture
* With concurrent major trauma, ex. intracranial hemorrhage, pneumothorax, hemothorax, internal bleeding.
* With prior history of femoral surgery
* With current or prior history of trauma or infection at femur
* With current diagnosis of coagulopathy
* With current or prior history of cancer
* With current or prior history of hematological disease
* Pregnancy
* Patients who will not cooperate with one-year followup
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aeon Biotechnology Corporation

INDUSTRY

Sponsor Role collaborator

Pei-Yuan Lee, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pei-Yuan Lee, MD

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pei-Yuan Lee, MD

Role: STUDY_CHAIR

Show Chwan Memorial Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Show Chwan Memorial Hospital

Changhua, Changhua, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hsin-Chuan Chen, MD

Role: CONTACT

+886975611139

Pei-Yuan Lee, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hsin-Chuan Chen, MD

Role: primary

+886975611139

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RD106049

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.